Everest Medicines Appoints Rogers Yongqing Luo as General Manager to Lead Next Stage of Company Growth

Everest Medicines Appoints Rogers Yongqing Luo as General Manager to Lead Next Stage of Company Growth

SHANGHAI, September 18, 2022 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest” or the “Company”), a biopharmaceutical company focused on developing and commercializing transformative pharmaceuticals to address critical unmet needs in Asia Pacific markets, announced the appointment of Rogers Yongqing Luo as the company’s chief executive officer, effective immediately. Mr. Luo will also serve as executive …

Everest Medicines Appoints Rogers Yongqing Luo as General Manager to Lead Next Stage of Company Growth Read More »